Point72 Asset Management’s Corvus Pharmaceuticals CRVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$28.2M Buy
2025
Q1
$8.86M Sell
2024
Q4
$16.2M Sell
2024
Q3
$29.4M Sell
2024
Q2
$10.9M Buy
2022
Q2
Sell
2022
Q1
$1.22M Sell
2021
Q4
$1.92M Buy
2021
Q3
$2.78M Buy
2017
Q4
Sell
2017
Q3
$3.11M Sell
2017
Q2
$2.81M Sell
2017
Q1
$8.48M Buy